Spinal cord stimulator lawsuits surge: what is going wrong?
Boston Scientific, Abbott, Nevro, and Medtronic face lawsuits over spinal cord stimulators, alleging patient harm. The global market is growing at 6.8% CAGR, with Medtronic holding a 29.8% US market share. Lawsuits stem from FDA recalls and reports of malfunctions, with Abbott disputing allegations. Trials are not yet scheduled.
How this was made
The 30-second read
Why it matters
Legal actions introduce uncertainty for revenue and profit forecasts of the involved firms.
Market read
The lawsuits could pressure the stocks of the four manufacturers and raise sector-wide risk considerations.
What to watch
Potential FDA actions or recall announcements could amplify the effect beyond the lawsuits.
Background
Spinal cord stimulators are a growing market for chronic pain management, with several major manufacturers facing new litigation.
Ticker impact
Boston Scientific is named as a defendant in new personal injury lawsuits over its spinal cord stimulator devices.
likely downward pressure as market prices in lawsuit risk
Lawsuits can lead to settlements or reputational damage, affecting earnings outlook.
Abbott faces personal injury lawsuits alleging harm from its spinal cord stimulator systems.
likely downward pressure as investors assess potential costs
Even without a trial date, the litigation adds uncertainty to Abbott's medical device segment.
Medtronic is a defendant in consolidated federal multidistrict litigation concerning its spinal cord stimulators.
likely pressure as investors factor in possible settlements or regulatory scrutiny
Medtronic holds the largest US market share in rechargeable SCS devices, amplifying potential impact.
Market effects
The medical device sector may see heightened scrutiny of neuromodulation products.
U.S. healthcare stocks could experience modest volatility.
Limited to companies with SCS product lines; broader market impact is minimal.
Counterpoint
If lawsuits are settled quickly or dismissed, the negative impact could be overstated.
Key entities
- CompanyBoston Scientific
Medical device maker sued over SCS devices
- CompanyAbbott
Healthcare company facing SCS litigation
- CompanyNevro
Specialist in neuromodulation devices sued
- CompanyMedtronic
Largest U.S. SCS market share, involved in MDL
